Skip to main content
SpringerLink
Log in

Mucocutaneous Side Effects and Continuation of Aurotherapy in Patients with Rheumatoid Arthritis

  • Chapter
Rheumaderm

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 455))

Abstract

To examine the possibility of the continuation of therapy after achieving clinical improvement in patients with mucocutaneous side-effects of parenteral gold compound therapy (Tauredonx00AE;, “Byk Gulden”, Germany)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Iannussi L., Dauson N., Zein N., Kushner J. Does drug therapy slow radiographic deterioration in rheumatoid arthritis. N Engl Med J 309, 1023–1028. 1983.

    Article  Google Scholar 

  2. Maxwell L., Smith D.M. 47 years experience in gold therapy in 1019 rheumatoid arthritis patients. Semin. Arthr Rheum. 14: 283–186. 1985.

    Google Scholar 

  3. Ward J.R., Williams N.J., Egger M.J., et al. Comparison of auronofin, gold sodium thiomalate and placebo in the treatment of rheumatoid arthritis. Arth Rheum 26: 1303–1315.1983.

    Article  CAS  Google Scholar 

  4. Kean W.F., Hart L., Buchanan W.W. Auronofin. Br J Rheumat. 36:560–572. 1997.

    Article  CAS  Google Scholar 

  5. Wilkinson S.M., Smith A.G., Davis J. et al. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis. 51:881–884. 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Kleinfelter F. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. J. Rheumatol. 2:21–27. 1975.

    Google Scholar 

  7. Cats A.A. A multicentre controlled trial of different dosage of gold therapy followed by a maintenance dosage. Agents Actions. 6:353–363. 1976.

    Article  Google Scholar 

  8. Sharp J.T., Lipsky M.D. Duffy J. et al. Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Arthr Rheum 20:1179–1187. 1977.

    Article  CAS  Google Scholar 

  9. Klinkhoff A.V., Teufel A. How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions. J. Rheumatol. 25:1657–1659. 1995.

    Google Scholar 

  10. Arnett F.C., Edworthy S.M., Bloch A.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 31:315–324. 1987.

    Article  Google Scholar 

  11. The OMERACT Committee Conference on Outcome Measures in Rheumatoid Arthritis. J. Rheumatol. 20:525–591.1993.

    Google Scholar 

  12. Felson D.T., Anderson J. J., Boers M. et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthr Rheum. 36:729–740. 1993.

    Article  CAS  Google Scholar 

  13. Fries J.F., Spitz P., Kraines R.G., Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum. 23:137–145. 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Pincus T., Summey J.A., Soraci S.A. Jr., et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 26:1346–1353. 1983.

    Article  PubMed  CAS  Google Scholar 

  15. Felson D.T., Anderson J.J., Boers M., et al. American College of rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38:727–735. 1995.

    Article  PubMed  CAS  Google Scholar 

  16. Atachodgaeva Z.A. The comparative efficacy of new gold preparations in rheumatoid arthritis. Dissertation, Moscow. P. 127. 1987.

    Google Scholar 

  17. Bendix G., Bjelle A. A 10 year follow up of paenteral gold therapy in patients with rheumatoid arthritis. Ann Rheum Dis. 55:169–176. 1996.

    Article  PubMed  CAS  Google Scholar 

  18. Smith R.T., Peak W.P., Kron K.M. et al. Increasing the effectiveness of gold therapy in rheumatoid arthritis. J Am Med Ass. 167:1197–2004. 1958.

    Article  CAS  Google Scholar 

  19. Jones G., Brooks P.M. Injectable gold compounds: an overview. Brit J Rheumatol. 35:1154–1158. 1996.

    Article  CAS  Google Scholar 

  20. Beresten T.I. The modified method of the treatment with Chrysanol by control of gold concentration in serum of patients with rheumatoid arthritis. Dissertation, Moscow. P. 131. 1979.

    Google Scholar 

  21. The Research Sub-committee of the Empire Rheumatism Council: Gold therapy in rheumatoid arthritis. Report of a mulci-centre controlled trial. Ann Rheum Dis. 20:198–202. 1961.

    Google Scholar 

  22. Caspi D., Tishler M., Yaron M. Association between gold induced skin rahs and remission in patients with rheumatoid arthritis. Ann Rheum Dis. 48:730–732. 1989.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia

    Dr. L. A. Taukumova

  2. “Byk Gulden”, Germany

    Yu. V. Mouravjoy

  3. Institute of Rheumatology, Russian Academy of Medical Sciences, Kashirshoye Shosse 34a, 115522, Moscow, Russia

    S. G. Gribakin

Authors
  1. Dr. L. A. Taukumova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu. V. Mouravjoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. G. Gribakin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Luke’s Hospital, University of Malta Medical School, Malta, USA

    Carmel Mallia

  2. Jefferson Medical College, Thomas Jefferson Universit, Philadelphia, Pennsylvania, USA

    Jouni Uitto

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Taukumova, L.A., Mouravjoy, Y.V., Gribakin, S.G. (1999). Mucocutaneous Side Effects and Continuation of Aurotherapy in Patients with Rheumatoid Arthritis. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_56

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4857-7_56

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7203-5

  • Online ISBN: 978-1-4615-4857-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation